3Ekaterina Rogaeva. The solved and unsolved mysteries of the genetics of early-onset Alzheimer’s disease[J] 2002,NeuroMolecular Medicine(1):1～10 被引量：1
4McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium[ J]. Neurology, 2005, 65 (12) : 1863-1872. 被引量：1
5Lamer AJ. Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships [ J ]. J Alzheimers Dis, 2013, 37(4): 653-659. DOI: 10.3233/JAD-130746. 被引量：1
6Matsushita S, Arai H, Okamura N, et al. Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer's disease[J]. Biol Psychiatry, 2002, 52(9) : 907-910. 被引量：1
7Ishikawa A, Piao YS, Miyashita A, et al. A mutant PSEN1 causes dementia with Lewy bodies and variant Alzheimer's disease [J]. Ann Neurol, 2005, 57(3) : 429-434. 被引量：1
8Snider B J, Norton J, Coats MA, et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life[J]. Arch Neurol, 2005, 62(12) : 1821- 1830. 被引量：1
9Balasa M, Gelpi E, Antonell A, et al. Clinical features and APOE genotype of pathologically proven early-onset Alzheimer disease[J]. Neurology, 2011, 76(20): 1720-1725. DOI: 10. 1212/WNL. 0b013 e31821 a44dd. 被引量：1
10Leverenz JB, Fishel MA, Peskind ER, et al. Lewy body pathology in familial Atzheimer disease: evidence for disease and mutation specific pathologic phenotype [J]. Arch Neurol, 2006, 63 (3) : 370-376. 被引量：1
